Kairos Pharma (KAPA) News Today $0.92 +0.02 (+2.14%) As of 08/1/2025 04:10 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesOwnershipSEC FilingsBuy This Stock KAPA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Kairos Pharma Announces Participation and Presentation in the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025July 16, 2025 | businesswire.comKairos Pharma Shares Surge on Prostate Cancer Study ResultsJuly 15, 2025 | marketwatch.comKairos Pharma Shares Surge on Promising Safety Data for Prostate Cancer TreatmentJuly 15, 2025 | msn.comWhy Is Kairos Pharma Stock Surging On Tuesday?July 15, 2025 | benzinga.comPromising Potential for Kairos Pharma’s ENV-105: Positive Safety Profile and Efficacy OutlookJuly 15, 2025 | tipranks.comKairos Pharma stock soars after positive safety data for cancer drugJuly 15, 2025 | za.investing.comKairos Pharma Announces Positive Safety Results from Phase 2 Trial of ENV-105 in Advanced Prostate CancerJuly 15, 2025 | finance.yahoo.comKairos Pharma Announces Positive Safety Results from Phase 2 Trial of ENV-105 in Advanced Prostate CancerJuly 15, 2025 | businesswire.comKAPA Kairos Pharma, Ltd.June 13, 2025 | seekingalpha.comKairos Pharma Ltd. Announces New Data on Small Molecule GITR Ligand Agonist KROS 101 as Promising Cancer Immunotherapy at the American Society of Clinical Oncology (ASCO) 2025 ...June 4, 2025 | finance.yahoo.comKairos Pharma Ltd. Announces New Data on Small Molecule GITR Ligand Agonist KROS 101 as Promising Cancer Immunotherapy at the American Society of Clinical Oncology (ASCO) 2025 Annual MeetingJune 3, 2025 | businesswire.comKairos Pharma, Ltd. Announces Participation in the D. Boral Capital Inaugural Global ConferenceMay 6, 2025 | finance.yahoo.comKairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual MeetingApril 28, 2025 | businesswire.comKairos Pharma Ltd. Provides Letter to StockholdersApril 24, 2025 | finance.yahoo.comKairos Pharma Ltd. Announces Department of Defense Grant to Support Its Study of Lead Compound ENV105 to Prevent Drug Resistance in Lung CancerApril 17, 2025 | finance.yahoo.comKairos Pharma initiated with a Buy at H.C. WainwrightApril 3, 2025 | markets.businessinsider.comHC Wainwright & Co. Initiates Coverage of Kairos Pharma (KAPA) with Buy RecommendationApril 3, 2025 | msn.comKairos Pharma Ltd (KAPA)April 2, 2025 | investing.comKairos Pharma completes safety lead-in of ENV105 trialApril 1, 2025 | markets.businessinsider.comKairos Pharma Ltd. Announces Completed Enrollment of the Safety Arm of Its Phase 2 Clinical Trial of ENV105 in Metastatic, Castration-Resistant Prostate CancerMarch 31, 2025 | businesswire.comKairos Pharma initiated with a Buy at MaximMarch 28, 2025 | markets.businessinsider.comCEO.CA's Inside the Boardroom: Kairos Pharma's Breakthrough Cancer Treatment & What's Next for ENV105March 28, 2025 | finance.yahoo.comMaxim Group Initiates Coverage of Kairos Pharma (KAPA) with Buy RecommendationMarch 28, 2025 | msn.comKairos Pharma Ltd. Highlights Participation in Recent and Upcoming Scientific and Industry EventsMarch 27, 2025 | businesswire.comKairos Pharma Ltd. Announces Peer Reviewed Publication Highlighting Potentially Groundbreaking Discovery in Overcoming Drug Resistance in Non-Small Cell Lung CancerMarch 20, 2025 | businesswire.comKairos Pharma presents preclinical data on KROS 101, KROS 401February 26, 2025 | markets.businessinsider.comKairos Pharma Presents Preclinical Data on its Investigational Compounds KROS 101 and KROS 401 Further Supporting Both Compounds' Potential as Therapeutics for Melanoma and GlioblastomaFebruary 26, 2025 | businesswire.com Get Kairos Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for KAPA and its competitors with MarketBeat's FREE daily newsletter. Email Address KAPA Media Mentions By Week KAPA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KAPA News Sentiment▼0.000.45▲Average Medical News Sentiment KAPA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KAPA Articles This Week▼01▲KAPA Articles Average Week Get Kairos Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for KAPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Assertio News Today Forte Biosciences News Today Biomea Fusion News Today Genenta Science News Today Cue Biopharma News Today Applied Therapeutics News Today Verrica Pharmaceuticals News Today Repare Therapeutics News Today PMV Pharmaceuticals News Today Quantum Biopharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:KAPA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kairos Pharma, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kairos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KAPA Stock Alerts